130 related articles for article (PubMed ID: 18093978)
1. Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modification.
Pham LV; Zhou HJ; Lin-Lee YC; Tamayo AT; Yoshimura LC; Fu L; Darnay BG; Ford RJ
J Biol Chem; 2008 Feb; 283(8):5081-9. PubMed ID: 18093978
[TBL] [Abstract][Full Text] [Related]
2. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex.
Dai YH; Hung LY; Chen RY; Lai CH; Chang KC
Transl Res; 2016 Sep; 175():129-143.e13. PubMed ID: 27150054
[TBL] [Abstract][Full Text] [Related]
3. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
4. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
5. Chordate PIAS proteins act as conserved repressors of the TRAF6 self-polyubiquitination.
Fu X; Wang R; Li M; Yan X; Huang H; Li J; Chen S; Yue Z; Chen S; Li Y; Dong M; Xu A; Huang S
Dev Comp Immunol; 2020 Mar; 104():103554. PubMed ID: 31758961
[TBL] [Abstract][Full Text] [Related]
6. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
7. Roles of TRAF6 in CD40 signaling.
Hostager BS
Immunol Res; 2007; 39(1-3):105-14. PubMed ID: 17917059
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling.
Tikhanovich I; Kuravi S; Artigues A; Villar MT; Dorko K; Nawabi A; Roberts B; Weinman SA
J Biol Chem; 2015 Sep; 290(36):22236-49. PubMed ID: 26221041
[TBL] [Abstract][Full Text] [Related]
11. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
12. TRAF6 regulates proliferation and differentiation of skeletal myoblasts.
Mueck T; Berger F; Buechsler I; Valchanova RS; Landuzzi L; Lollini PL; Klingel K; Munz B
Differentiation; 2011 Feb; 81(2):99-106. PubMed ID: 21131124
[TBL] [Abstract][Full Text] [Related]
13. Developmental stage-dependent collaboration between the TNF receptor-associated factor 6 and lymphotoxin pathways for B cell follicle organization in secondary lymphoid organs.
Qin J; Konno H; Ohshima D; Yanai H; Motegi H; Shimo Y; Hirota F; Matsumoto M; Takaki S; Inoue J; Akiyama T
J Immunol; 2007 Nov; 179(10):6799-807. PubMed ID: 17982070
[TBL] [Abstract][Full Text] [Related]
14. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
15. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
Morlon A; Munnich A; Smahi A
Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
17. A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit.
Meads MB; Li ZW; Dalton WS
J Immunol; 2010 Aug; 185(3):1606-15. PubMed ID: 20622119
[TBL] [Abstract][Full Text] [Related]
18. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination.
Wooten MW; Geetha T; Seibenhener ML; Babu JR; Diaz-Meco MT; Moscat J
J Biol Chem; 2005 Oct; 280(42):35625-9. PubMed ID: 16079148
[TBL] [Abstract][Full Text] [Related]
19. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
Wu L; Nakano H; Wu Z
J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
